ClinicalTrials.Veeva

Menu

One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma (OSNA-ORL)

R

Rennes University Hospital

Status

Completed

Conditions

cN0 Oral Squamous Cell Carcinomas

Study type

Observational

Funder types

Other

Identifiers

NCT02852343
35RC14_9878

Details and patient eligibility

About

The investigators main objective is to show that OSNA technique is as accurate as pathological analysis (frozen section / HE staining and immunochemistry) to detect occult lymph node metastasis (micro and macrometastasis).

Enrollment

26 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient > 18 years old
  • Head and neck squamous cell carcinoma diagnosed by biopsy
  • N0 classification (N0: no lymph node invasion on clinical and radiological examination).
  • Neck dissection or sentinel lymph node biopsy required to treat the patient
  • ECOG 1,2 or 3
  • Patient's consent

Exclusion criteria

  • Patient previously treated by radiotherapy or surgery for head and neck neoplasm.
  • Contraindication or patient unwillingness to undergo surgical treatment
  • Incapacitated adults

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems